163 related articles for article (PubMed ID: 22201845)
1. Nuclear receptor control of opposing macrophage phenotypes in cardiovascular disease.
Frieler RA; Ramnarayanan S; Mortensen RM
Front Biosci (Landmark Ed); 2012 Jan; 17(5):1917-30. PubMed ID: 22201845
[TBL] [Abstract][Full Text] [Related]
2. Heme oxygenase-2 deletion impairs macrophage function: implication in wound healing.
Bellner L; Marrazzo G; van Rooijen N; Dunn MW; Abraham NG; Schwartzman ML
FASEB J; 2015 Jan; 29(1):105-15. PubMed ID: 25342128
[TBL] [Abstract][Full Text] [Related]
3. Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men.
Rigamonti E; Chinetti-Gbaguidi G; Staels B
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1050-9. PubMed ID: 18323516
[TBL] [Abstract][Full Text] [Related]
4. Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation.
Castrillo A; Tontonoz P
Annu Rev Cell Dev Biol; 2004; 20():455-80. PubMed ID: 15473848
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid receptors, macrophages and cardiovascular disease.
Rickard AJ; Young MJ
J Mol Endocrinol; 2009 Jun; 42(6):449-59. PubMed ID: 19158233
[TBL] [Abstract][Full Text] [Related]
6. Control of macrophage activation and function by PPARs.
Chawla A
Circ Res; 2010 May; 106(10):1559-69. PubMed ID: 20508200
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
Chinetti G; Fruchart JC; Staels B
Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
[TBL] [Abstract][Full Text] [Related]
8. Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease.
Takano H; Komuro I
J Diabetes Complications; 2002; 16(1):108-14. PubMed ID: 11872377
[TBL] [Abstract][Full Text] [Related]
9. M1/M2 Macrophages in Diabetic Nephropathy: Nrf2/HO-1 as Therapeutic Targets.
Landis RC; Quimby KR; Greenidge AR
Curr Pharm Des; 2018; 24(20):2241-2249. PubMed ID: 30014796
[TBL] [Abstract][Full Text] [Related]
10. Nuclear receptor signaling in macrophages.
Valledor AF; Ricote M
Biochem Pharmacol; 2004 Jan; 67(2):201-12. PubMed ID: 14698033
[TBL] [Abstract][Full Text] [Related]
11. Macrophage polarization in inflammatory diseases.
Liu YC; Zou XB; Chai YF; Yao YM
Int J Biol Sci; 2014; 10(5):520-9. PubMed ID: 24910531
[TBL] [Abstract][Full Text] [Related]
12. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.
Ricote M; Li AC; Willson TM; Kelly CJ; Glass CK
Nature; 1998 Jan; 391(6662):79-82. PubMed ID: 9422508
[TBL] [Abstract][Full Text] [Related]
13. Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: implications for cardiovascular disease.
Tontonoz P; Nagy L
Curr Opin Lipidol; 1999 Dec; 10(6):485-90. PubMed ID: 10680041
[TBL] [Abstract][Full Text] [Related]
14. Narrowing in on cardiovascular disease: the atheroprotective role of peroxisome proliferator-activated receptor gamma.
Gerry JM; Pascual G
Trends Cardiovasc Med; 2008 Feb; 18(2):39-44. PubMed ID: 18308193
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptors in the cardiovascular system.
Bishop-Bailey D
Br J Pharmacol; 2000 Mar; 129(5):823-34. PubMed ID: 10696077
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptors in macrophage biology: friend or foe?
Moore KJ; Fitzgerald ML; Freeman MW
Curr Opin Lipidol; 2001 Oct; 12(5):519-27. PubMed ID: 11561171
[TBL] [Abstract][Full Text] [Related]
17. Potential roles of the peroxisome proliferator-activated receptor-gamma in macrophage biology and atherosclerosis.
Glass CK
J Endocrinol; 2001 Jun; 169(3):461-4. PubMed ID: 11375116
[No Abstract] [Full Text] [Related]
18. Transcriptional regulation of macrophage cholesterol trafficking by PPARalpha and LXR.
Chinetti G; Fruchart JC; Staels B
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1128-31. PubMed ID: 17073767
[TBL] [Abstract][Full Text] [Related]
19. Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants.
Weis N; Weigert A; von Knethen A; Brüne B
Mol Biol Cell; 2009 Mar; 20(5):1280-8. PubMed ID: 19129475
[TBL] [Abstract][Full Text] [Related]
20. Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension.
Vergadi E; Chang MS; Lee C; Liang OD; Liu X; Fernandez-Gonzalez A; Mitsialis SA; Kourembanas S
Circulation; 2011 May; 123(18):1986-95. PubMed ID: 21518986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
